GTH 2026: Connected Science – Advanced Solutions
Hämostaseologie · 01.02.2026 · 46 (01) · 005-006
DOI: 10.1055/a-2661-6103 ↗Kurz gefasst
Editorial in der Zeitschrift Hämostaseologie, erschienen am 01.02.2026. Verfasst von Johannes Oldenburg und 1 weiteren Autor:innen. Beteiligte Einrichtung: Insitute of Experimental Haematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany. Hauptthemen laut MEDLINE: Genetic Therapy, Hemophilia A. Die Arbeit nennt 8 Literaturangaben.
Abstract (Originalsprache)
Research into the molecular mechanisms of hereditary haemostatic disorders has provided significant insights into the fundamental mechanisms of the haemostatic system. Examples of such disorders include haemophilia A and von Willebrand disease. Meanwhile, findings from basic science research have enabled the development of new therapeutic approaches. One such approach is gene therapy for haemophilia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Insitute of Experimental Haematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany.
Zitieren
APA
Oldenburg, J., & Pötzsch, B. (2026). GTH 2026: Connected Science – Advanced Solutions. Hämostaseologie, 46(01), 005-006. https://doi.org/10.1055/a-2661-6103
Vancouver
Oldenburg J, Pötzsch B. GTH 2026: Connected Science – Advanced Solutions. Hämostaseologie. 2026;46(01):005-006. doi:10.1055/a-2661-6103
BibTeX
@article{Oldenburg2026,
author = {Oldenburg, Johannes and Pötzsch, Bernd},
title = {GTH 2026: Connected Science – Advanced Solutions},
journal = {Hämostaseologie},
year = {2026},
volume = {46},
number = {01},
pages = {005--006},
doi = {10.1055/a-2661-6103}
}
EUVIMED